C J Ferro

Summary

Affiliation: University Hospital Birmingham
Country: UK

Publications

  1. pmc The natural history of, and risk factors for, progressive chronic kidney disease (CKD): the Renal Impairment in Secondary care (RIISC) study; rationale and protocol
    Stephanie Stringer
    Department of Nephrology, University Hospital Birmingham, Birmingham B15 2WB, UK
    BMC Nephrol 14:95. 2013
  2. pmc Cardiovascular effects of sevelamer in stage 3 CKD
    Colin D Chue
    Schools of Clinical and Experimental Medicine, University of Birmingham, Birmingham, United Kingdom
    J Am Soc Nephrol 24:842-52. 2013
  3. pmc Evaluating the effects of sevelamer carbonate on cardiovascular structure and function in chronic renal impairment in Birmingham: the CRIB-PHOS randomised controlled trial
    Colin D Chue
    Department of Nephrology, Queen Elizabeth Hospital and University of Birmingham, Birmingham, UK
    Trials 12:30. 2011
  4. doi request reprint Does immunosuppressant medication lower blood pressure and arterial stiffness in patients with chronic kidney disease? An observational study
    Charles J Ferro
    Department of Nephrology, University of Birmingham and University Hospital Birmingham, Birmingham, UK
    Hypertens Res 34:113-9. 2011
  5. doi request reprint Is lowering phosphate exposure the key to preventing arterial stiffening with age?
    C J Ferro
    Department of Nephrology, Queen Elizabeth Hospital, University Hospital Birmingham NHS Foundation Trust, Edgbaston, Birmingham, West Midlands B15 2TH, UK
    Heart 95:1770-2. 2009
  6. doi request reprint Serum phosphate is associated with left ventricular mass in patients with chronic kidney disease: a cardiac magnetic resonance study
    Colin D Chue
    Department of Cardiology, University Hospitals Birmingham NHS Foundation Trust, UK
    Heart 98:219-24. 2012
  7. doi request reprint Understanding the effects of chronic kidney disease on cardiovascular risk: are there lessons to be learnt from healthy kidney donors?
    W E Moody
    Department of Cardiovascular Medicine, Queen Elizabeth Hospital, University of Birmingham, Birmingham, UK
    J Hum Hypertens 26:141-8. 2012
  8. doi request reprint Aortic distensibility and arterial-ventricular coupling in early chronic kidney disease: a pattern resembling heart failure with preserved ejection fraction
    N C Edwards
    Department of Cardiology, University of Birmingham and University Hospital Birmingham, Birmingham, UK
    Heart 94:1038-43. 2008
  9. ncbi request reprint The treatment of coronary artery disease in patients with chronic kidney disease
    N C Edwards
    Research Fellow in Cardiology, Department of Cardiovascular Medicine, University of Birmingham, Birmingham, UK
    QJM 99:723-36. 2006
  10. doi request reprint Serum phosphate but not pulse wave velocity predicts decline in renal function in patients with early chronic kidney disease
    Colin D Chue
    Department of Cardiology, Queen Elizabeth Hospital, Birmingham and University of Birmingham, Birmingham, UK
    Nephrol Dial Transplant 26:2576-82. 2011

Collaborators

  • Lorraine Harper
  • Nicola C Edwards
  • Daniel Zehnder
  • Colin D Chue
  • Richard P Steeds
  • Jonathan N Townend
  • Stephanie Stringer
  • William E Moody
  • W E Moody
  • Iain Chapple
  • Mark Jesky
  • Praveen Sharma
  • Nadezhda A Wall
  • Mary Dutton
  • Khai Ng
  • Paul Cockwell
  • Okdeep Kaur
  • Thomas Dietrich
  • N G Inston
  • J N Townend
  • C D Chue
  • R P Steeds
  • Laura J Davis

Detail Information

Publications10

  1. pmc The natural history of, and risk factors for, progressive chronic kidney disease (CKD): the Renal Impairment in Secondary care (RIISC) study; rationale and protocol
    Stephanie Stringer
    Department of Nephrology, University Hospital Birmingham, Birmingham B15 2WB, UK
    BMC Nephrol 14:95. 2013
    ..Accurate mapping of the bio-clinical determinants of this group will enable improved risk stratification and direct the development of better targeted management for people with CKD...
  2. pmc Cardiovascular effects of sevelamer in stage 3 CKD
    Colin D Chue
    Schools of Clinical and Experimental Medicine, University of Birmingham, Birmingham, United Kingdom
    J Am Soc Nephrol 24:842-52. 2013
    ..In conclusion, this study does not provide evidence that sevelamer carbonate improves LV mass, LV function, or arterial stiffness in stage 3 nondiabetic CKD...
  3. pmc Evaluating the effects of sevelamer carbonate on cardiovascular structure and function in chronic renal impairment in Birmingham: the CRIB-PHOS randomised controlled trial
    Colin D Chue
    Department of Nephrology, Queen Elizabeth Hospital and University of Birmingham, Birmingham, UK
    Trials 12:30. 2011
    ..TRIAL REGISTRATION: This trial is registered at ClinicalTrials.gov: NCT00806481 and Current Controlled Trials: ISRCTN35254279...
  4. doi request reprint Does immunosuppressant medication lower blood pressure and arterial stiffness in patients with chronic kidney disease? An observational study
    Charles J Ferro
    Department of Nephrology, University of Birmingham and University Hospital Birmingham, Birmingham, UK
    Hypertens Res 34:113-9. 2011
    ..5 ± 1.8 vs. 8.8 ± 1.9 m s(-1); P = 0.02). This study suggests that immunosuppression might be a method of reducing blood pressure and arterial stiffness in patients with chronic kidney disease...
  5. doi request reprint Is lowering phosphate exposure the key to preventing arterial stiffening with age?
    C J Ferro
    Department of Nephrology, Queen Elizabeth Hospital, University Hospital Birmingham NHS Foundation Trust, Edgbaston, Birmingham, West Midlands B15 2TH, UK
    Heart 95:1770-2. 2009
    ..It is hypothesised that reducing phosphate intake will attenuate the progression of arterial stiffness with major beneficial effects upon cardiovascular mortality and morbidity...
  6. doi request reprint Serum phosphate is associated with left ventricular mass in patients with chronic kidney disease: a cardiac magnetic resonance study
    Colin D Chue
    Department of Cardiology, University Hospitals Birmingham NHS Foundation Trust, UK
    Heart 98:219-24. 2012
    ..To explore the relationship between serum phosphate, arterial stiffness and left ventricular mass (LVM) in patients with early-stage chronic kidney disease (CKD)...
  7. doi request reprint Understanding the effects of chronic kidney disease on cardiovascular risk: are there lessons to be learnt from healthy kidney donors?
    W E Moody
    Department of Cardiovascular Medicine, Queen Elizabeth Hospital, University of Birmingham, Birmingham, UK
    J Hum Hypertens 26:141-8. 2012
    ....
  8. doi request reprint Aortic distensibility and arterial-ventricular coupling in early chronic kidney disease: a pattern resembling heart failure with preserved ejection fraction
    N C Edwards
    Department of Cardiology, University of Birmingham and University Hospital Birmingham, Birmingham, UK
    Heart 94:1038-43. 2008
    ..To examine arterial and left ventricular function and their interaction in patients with early-stage chronic kidney disease (CKD)...
  9. ncbi request reprint The treatment of coronary artery disease in patients with chronic kidney disease
    N C Edwards
    Research Fellow in Cardiology, Department of Cardiovascular Medicine, University of Birmingham, Birmingham, UK
    QJM 99:723-36. 2006
    ..The high rate of late adverse cardiovascular events after both CABG and angioplasty accentuates the need for effective secondary preventive therapy disease in these high-risk patients...
  10. doi request reprint Serum phosphate but not pulse wave velocity predicts decline in renal function in patients with early chronic kidney disease
    Colin D Chue
    Department of Cardiology, Queen Elizabeth Hospital, Birmingham and University of Birmingham, Birmingham, UK
    Nephrol Dial Transplant 26:2576-82. 2011
    ..We sought to determine whether serum phosphate and markers of arterial stiffness predict progression of renal dysfunction in patients with early CKD...